TheIMPT.org
  • About
    ▲
    • What We Do
    • Who We Are
      ▲
      • Global MPT Collaborative Networks
    • Contact Us
  • Resources
    ▲
    • What are MPTs?
    • MPT Resource Center
    • MPT Product Database
    • Funding Opportunities
    • Trainee & Career Resources
    • IMPT Newsletter
    • Events Calendar
  • NEWS + MEDIA
    ▲
    • In the Media
    • Blog
Skip to content
The IMPT Logo
  • About
    • What We Do
    • Who We Are
      • Global MPT Collaborative Networks
    • Contact Us
  • Resources
    • What are MPTs?
    • MPT Resource Center
    • MPT Product Database
    • Funding Opportunities
    • Trainee & Career Resources
    • IMPT Newsletter
    • Events Calendar
  • NEWS + MEDIA
    • In the Media
    • Blog
  • Menu

The Initiative for Multipurpose Prevention Technologies

Category Archives: Press Release

Non-Hormonal Intra-Vaginal Ring Contraceptive to be Developed by QPharma AB and BioRings LLC

Non-Hormonal Intra-Vaginal Ring Contraceptive to be Developed by QPharma AB and BioRings LLC

Non-Hormonal Intra-Vaginal Ring Contraceptive to be Developed by QPharma AB and BioRings LLC 02 April 2015 click to view Press Release In this Press Release: Health Risk(s): Unintended Pregnancy Product Type(s): IVR (Intravaginal Rings) Topic(s): Product Development

Continue reading→
Population Council’s MZC outperforms TFV 1 percent gel in microbicide candidate preclinical study

Population Council’s MZC outperforms TFV 1 percent gel in microbicide candidate preclinical study

Population Council’s MZC outperforms TFV 1 percent gel in microbicide candidate preclinical study 24 November 2015 click to view Press Release In this Press Release: Health Risk(s): HIV Product Type(s): Microbicides Vaginal Cream/Gel Topic(s): Product Trials

Continue reading→

Population Council to determine feasibility of fast-tracking oral contraceptive multipurpose prevention technology (cMPT) development

Continue reading→
Population Council Launches Phase 1 Clinical Trial of a Novel Microbicide Gel to Prevent HIV and Other STIs

Population Council Launches Phase 1 Clinical Trial of a Novel Microbicide Gel to Prevent HIV and Other STIs

Population Council Launches Phase 1 Clinical Trial of a Novel Microbicide Gel to Prevent HIV and Other STIs 29 September 2014 click to view Press Release In this Press Release: Health Risk(s): HIV STI / STD Product Type(s): Microbicides Topic(s): Product Development

Continue reading→
Regulatory clearance opens the way for new single-size contraceptive diaphragm in the United States

Regulatory clearance opens the way for new single-size contraceptive diaphragm in the United States

Regulatory clearance opens the way for new single-size contraceptive diaphragm in the United States 09 September 2014 click to view Press Release In this Press Release: Health Risk(s): Unintended Pregnancy Product Type(s): Diaphragm Topic(s): Product Development

Continue reading→

Researchers at Queen’s University Belfast have developed a vaginal ring capable of providing sustained delivery of OB-002 (5P12-RANTES) for HIV prevention

Continue reading→

Rise in prevalence of STDs reported by CDC supports continued development of novel solutions, like Evofem’s product in development, Amphora, for the prevention of chlamydia

Continue reading→
SRI Awarded $150 Million NIAID-DAIDS Contract to Provide Development and Manufacturing Support for Promising HIV-Prevention Products

SRI Awarded $150 Million NIAID-DAIDS Contract to Provide Development and Manufacturing Support for Promising HIV-Prevention Products

SRI Awarded $150 Million NIAID-DAIDS Contract to Provide Development and Manufacturing Support for Promising HIV-Prevention Products 06 December 2016 click to view Press Release In this Press Release: Health Risk(s): HIV Product Type(s): MPTs Topic(s): Product Development

Continue reading→

The Division of AIDS Awards ABL a Seven-Year Contract to Provide HIV Microbicide Research and Product Development Support

The Division of AIDS Awards ABL a Seven-Year Contract to Provide HIV Microbicide Research and Product Development Support 26 July 2016 click to view Press Release In this Press Release: Health Risk(s): HIV Product Type(s): Microbicides Topic(s): Funding

Continue reading→

The Female Health Company Donates Female Condoms, to Work with CDC on Education and Training, as Part of STD Awareness Month

The Female Health Company Donates Female Condoms, to Work with CDC on Education and Training, as Part of STD Awareness Month 09 May 2016 click to view Press Release In this Press Release: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): Condoms Topic(s): Advocacy Education

Continue reading→

Post navigation

« Previous 1 2 3 4 5 Next »

DONATE

IMPT Secretariat
1750 Howe Avenue, Suite 550
Sacramento, CA 95825
IMPT@cami-health.org
Contact Us

The Initiative for Multipurpose Prevention Technologies (IMPT) is a project of CAMI Health, a social impact organization dedicated to improving the health of women and their families worldwide. CAMI Health is housed at the Public Health Institute (PHI).

This project is made possible by the generous support of the National Institutes of Health (NIH) through contract #75N94021P00910. The contents of this website are the sole responsibility of the IMPT, CAMI Health, PHI, and its partners and do not necessarily reflect the views of NIH or the United States Government.


© Copyright 2023, Public Health Institute / CAMI Health / IMPT Secretariat. All rights reserved.

  • NIH
  • Public Heath Intitute
  • CAMI Health

Please complete this brief form for inquiries about the MPT Product Development Database, MPT Priority Action Areas, MPT Funding Opportunities, and/or other MPT related questions.

  • This field is for validation purposes and should be left unchanged.